Measuring the Impact of the Food and Drug Administration (Fda) Unapproved Drug Initiative (Udi) on Drug Prices and Expenditures
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.1555
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV